Informations sur le produit
2-Aminobenzamide oxime is a monoclonal antibody that has been conjugated to an acceptor. This antibody is currently in clinical development for the treatment of cancer. The 2-aminobenzamide moiety of this drug is a reactive group that can be used to introduce a linker to the antibody. The linker can then be used to covalently bind a targeting agent, such as a cytotoxic agent or drug, to the 2-aminobenzamide moiety. This drug has been shown to have fluorescence properties and is being studied for its use as a radiolabeling agent for positron emission tomography (PET) imaging and as a tumor-targeting agent in cancer therapy.
2-Aminobenzamide oxime has also been used in kinetic studies for binding interactions with proteins and peptides, which could lead to analytical methods for measuring protein binding constants or reaction rates in vitro and in vivo.
